When the World Trade Centers evaporated on 9/11, clouds of toxic chemicals were left in their wake. Researchers wanted to know the impact of these clouds on the health of rescue workers.

Zytiga ( abiraterone acetate) received expanded use approval to treat men with advanced prostate cancer last week. In addition to extending lives, a new study has found Zytiga also keeps men feeling better during their journey.

Men with metastatic prostate cancer may have a new treatment.  Radium-223 dichloride (radium-223) is designed to treat castration-resistant prostate cancer that has spread to the bone.

Patients with advanced prostate cancer may have cancer cells that spread to the bone and cause pain. A new drug shows promise by rapidly reducing prostate cancer bone tumors.

Men with castration-resistant prostate cancer have another treatment option. The US Food and Drug Administration (FDA) has approved the expanded use of Zytiga (abiraterone acetate).

You may have heard that a glass of red wine a day is good for your heart. Research now shows that the beneficial compound found in red wine may also help fight prostate cancer.

For men with aggressive prostate cancer, few treatment options are available. A new drug, however, showed a positive effect in reducing the number of tumor cells and cancer markers in advanced prostate cancer.

Prostate cancer is the most common non-skin cancer in men. While some specialty organizations recommend that screening begin at age 40, there is little evidence showing real benefits to screening at this age.